Pay in 4 interest-free payments of $6.41 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
It belongs to a newer class of drugs sometimes called incretin or multi-agonist peptide therapies the same broad family as semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound)
Many of the benefits are lost when food is cooked, however
92% of patients who lost 5%+ by week 12 went on to achieve at least 15% total weight loss by week 48
The goal is building a plan patients can actually stay on
Some patients may experience mild nausea, indigestion, or changes in bowel habits as their body gets used to the medication
Semaglutide is contraindicated in patients with a personal or family history of medullary thyroid cancer (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
US$ 26.92
US$ 21.39
US$ 22.26
